USPTO trademark

IZRIUS

RegisteredUSPTOWord markClass 5

"IZRIUS" is a word mark owned by Glaxo Group Limited, filed at the USPTO on December 16, 2019. It is registered and covers class 5 (Pharmaceuticals).

View Glaxo Group Limited portfolioGet this data via the API
Official USPTO record
IZRIUS trademark as filed
As filed with the USPTO
Status
Registered
Since June 2, 2020
Filed
December 16, 2019
Registered
June 2, 2020
Priority date
August 13, 2019
Claimed from United Kingdom
Application no.
88728759
Registration no.
6069534
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns IZRIUS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Glaxo Group Limited

Stevenage, United Kingdom

19,383 trademarks in the portfolioView company

Representative

Elizabeth K. Rucki

GlaxoSmithKline

Goods and services

What the mark covers

The products and services IZRIUS is filed for, grouped by Nice class.

  • Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Courtesy reminder - sec. 8 (6-yr) e-mailed
  2. Teas change of correspondence received
  3. Attorney/dom.rep.revoked and/or appointed
  4. Teas revoke/app/change addr of atty/dom rep received
  5. Applicant/correspondence changes (non-responsive) entered
  6. Teas change of owner address received
  7. Applicant/correspondence changes (non-responsive) entered
  8. Teas change of correspondence received
  9. Attorney/dom.rep.revoked and/or appointed
  10. Teas revoke/app/change addr of atty/dom rep received

9 earlier steps on the official record.

FAQ

About IZRIUS

Who owns the trademark "IZRIUS"?

The USPTO trademark "IZRIUS" (application 88728759) is owned by Glaxo Group Limited.

What is the status of "IZRIUS"?

Its status at the USPTO is: registered.

When was "IZRIUS" registered?

It was registered on June 2, 2020.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull IZRIUS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b3b-361b-705d-9f68-faeca7d9f9cc
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b3b-361b-705d-9f68-faeca7d9f9cc",
  "object": "trademark",
  "mark_text": "IZRIUS",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "88728759",
  "filing_date": "2019-12-16",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Glaxo Group Limited",
      "entity_id": "ent_019eb6f6-4cb9-77ae-916f-63b3231a6d3d"
    }
  ]
}